Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. www.hookipa.clHookipa

    Books&Bits; Hookipa Sport; Home; Ayuda; Contacto; Sucursales; Mis ordenes; Inicio sesión; Registro

    • Home

      Books&Bits; Hookipa Sport; Home; Ayuda; Contacto;...

    • Ayuda

      En el caso que el cambio se efectúe por falla de producto...

    • Contacto

      Hookipa en tu email Suscríbete Términos y condiciones...

    • Sucursales

      Sucursales - Hookipa

  2. www.hookipa.cl › sucursalesHookipa

    Términos y condiciones Hookipa 2024 todos los derechos reservados Dirección: Moro Av. Apoquindo 7331 local 108 - contacto@hookipa.cl Dirección: Moro Av. Apoquindo 7331 local 108 - contacto@hookipa.cl

  3. www.hookipa.cl › catalogoHookipa

    Inicio Sesión. Login. Registro. ¿Olvidaste tu contraseña? Hookipa en tu email. Suscríbete. Términos y condiciones Hookipa 2024 todos los derechos reservados Dirección: Moro Av. Apoquindo 7331 local 108 - contacto@hookipa.cl.

  4. 9 de may. de 2024 · Hookipa Pharma is a clinical stage company that develops products to prevent and cure serious diseases using a proprietary arenavirus platform. The platform can engineer arenaviral therapeutics that mobilize and amplify targeted T cells and antibodies, the body's natural infection killers.

  5. www.hookipapharma.com › our-programs › our-pipelinePipeline - Hookipa Pharma

    Hookipa Pharma is a biotech company developing a new class of immunotherapeutics based on engineered viruses. Learn about their pipeline of product candidates for multiple cancers and infectious diseases, and their modular arenavirus platform.

  6. 20 de oct. de 2022 · HOOKIPA Pharma, a company developing arenaviral immunotherapies, announces a strategic collaboration and license agreement with Roche to develop HB-700 for KRAS-mutated cancers. HB-700 is a replicating 2-vector therapy that targets the most common KRAS mutations and induces potent T cell responses.

  7. 9 de nov. de 2021 · HOOKIPA Pharma is a biotech company developing immunotherapeutics based on its arenavirus platform. Read the latest news on its Phase 2 HB-201 program for head and neck cancer, its oncology pipeline, and its CMV vaccine candidate HB-101.

  1. Otras búsquedas realizadas